Richard Morphy
Impact in
- Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Chemical Synthesis and Analysis 6
- Receptor Mechanisms and Signaling 4
- Pharmacological Receptor Mechanisms and Effects 2
- Ion channel regulation and function 1
-
- Click Chemistry and Applications 7
- Co-authors
- Zoran Ranković (7 shared papers)Corinne Kay (1 shared paper)David C. Rees (1 shared paper)David Gani (1 shared paper)Andrew Mountain (2 shared papers)N. Willmott (2 shared papers)John Porter (2 shared papers)Andrew Docherty (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (4 papers)Drug Discovery Today (2 papers)Journal of Pharmaceutical Sciences (1 paper)Tetrahedron Letters (1 paper)
- Partner nations
- United KingdomFranceJapan
In The Last Decade
Richard Morphy
16 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Computational Theory and Mathematics 804
- Pharmacology 623
- Organic Chemistry 932
- Toxicology 69
- Molecular Biology 1.3k
Countries citing papers authored by Richard Morphy
This map shows the geographic impact of Richard Morphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Morphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Morphy more than expected).
Fields of papers citing papers by Richard Morphy
This network shows the impact of papers produced by Richard Morphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Morphy. The network helps show where Richard Morphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Morphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Designed Multiple Ligands. An Emerging Drug Discovery Paradigm Hit paper breakdown → | 2005 | 1002 |
| 2 | From magic bullets to designed multiple ligands Hit paper breakdown → | 2004 | 583 |
| 3 | 2009 | 219 | |
| 4 | 2009 | 203 | |
| 5 | 2006 | 159 | |
| 6 | 2006 | 143 | |
| 7 | 2006 | 82 | |
| 8 | 1997 | 53 | |
| 9 | 1997 | 48 | |
| 10 | 2010 | 18 | |
| 11 | 2010 | 16 | |
| 12 | Lead Generation Approaches in Drug Discovery | 2010 | 11 |
| 13 | 1995 | 10 | |
| 14 | 2004 | 10 | |
| 15 | 2006 | 10 | |
| 16 | 2010 | 3 |
About Richard Morphy
Richard Morphy is a scholar working on Molecular Biology, Organic Chemistry, Computational Theory and Mathematics, Cellular and Molecular Neuroscience and Biotechnology, having authored 16 papers that have together received 2.6k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (8 papers), Click Chemistry and Applications (7 papers), Chemical Synthesis and Analysis (6 papers), Receptor Mechanisms and Signaling (4 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers), Ion channel regulation and function (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Computational Theory and Mathematics (804 citations), Pharmacology (623 citations), Organic Chemistry (932 citations), Toxicology (69 citations) and Molecular Biology (1.3k citations). Richard Morphy has collaborated with scholars based in United Kingdom, France and Japan. Frequent co-authors include Zoran Ranković, Corinne Kay, David C. Rees, David Gani, Andrew Mountain, N. Willmott, John Porter, Andrew Docherty, Surinder K. Chander and Andrew T. Millican. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Drug Discovery Today, Journal of Pharmaceutical Sciences and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.